This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Tonsil
CD2_BENIGN_TONSIL_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10
- Name in latin
- Neoplasma benignum tonsillae palatinae
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Tonsil
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Tonsil
- Benign neoplasm of mouth and pharynx
- Benign neoplasm of mouth and pharynx
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 415 | 245 | 170 |
| Unadjusted period prevalence (%) | 0.08 | 0.08 | 0.07 |
| Median age at first event (years) | 59.35 | 56.63 | 63.26 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 367
- Matched controls
- 3670
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D10.4
ICD-10 Finland
Benign neoplasm: Tonsil
+∞
323.0
353
*
130
Kela drug reimbursment
Malignant tumour
+∞
72.3
67
*
EMA10
NOMESCO Finland
Biopsy of tonsil
420.5
70.1
68
*
WF002
NOMESCO Finland
Radical radiotherapy
533.9
48.5
47
*
C09.0
ICD-10 Finland
Malignant neoplasm: Tonsillar fossa
+∞
44.7
42
*
H02AB02
ATC
dexamethasone; systemic
48.0
41.5
50
12
A04AA02
ATC
granisetron; systemic, transdermal
+∞
41.4
39
*
EMB10
NOMESCO Finland
Tonsillectomy
10.4
38.4
79
94
C09.9
ICD-10 Finland
Malignant neoplasm: Tonsil, unspecified
+∞
38.2
36
*
A03FA01
ATC
metoclopramide; systemic, rectal
6.6
37.7
109
221
8070/3-C09.9
ICD-O-3
Squamous cell carcinoma, NOS, of tonsil, NOS
+∞
35.0
33
*
ENA10
NOMESCO Finland
Biopsy of pharynx
369.7
34.5
34
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
31.7
30
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
77.0
31.5
35
5
EP1AE
NOMESCO Finland
Neck ultrasound examination
11.2
28.9
56
58
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
279.2
26.0
26
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
37.4
24.7
31
9
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
17.2
22.9
36
23
UDQ12
NOMESCO Finland
Flexible laryngoscopy
7.6
21.6
52
78
XX3DW
NOMESCO Finland
Time consuming IT work
8.0
21.5
50
71
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
64.0
21.1
24
*
N02AA05
ATC
oxycodone; systemic
4.9
20.6
72
173
C09.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of tonsil
+∞
20.0
19
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
20.9
19.8
29
15
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
210.9
19.8
20
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
18.9
18
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
18.9
18
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
18.9
18
*
JN4BD
NOMESCO Finland
Extensive body CT
7.5
18.7
45
67
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.9
18.0
137
619
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
16.8
16
*
115
Kela drug reimbursment
Breast cancer
+∞
16.8
16
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
94.4
16.7
18
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
177.7
16.6
17
*
J35.1
ICD-10 Finland
Hypertrophy of tonsils
22.2
16.2
23
11
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
15.7
15
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
30.1
15.3
20
7
Z51.5
ICD-10 Finland
Palliative care
14.8
15.3
25
18
A04AA01
ATC
ondansetron; systemic, rectal
9.5
14.8
30
34
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
83.5
14.7
16
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
14.7
14
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
14.7
14
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
14.7
14
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
14.4
120
558
8070/3-C09.0
ICD-O-3
Squamous cell carcinoma, NOS, of tonsillar fossa
+∞
13.6
13
*
ZXE00
NOMESCO Finland
One hour or less
2.4
13.6
170
981
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
51.9
12.9
15
*
R07.0
ICD-10 Finland
Pain in throat
5.0
12.7
41
90
UDH02
NOMESCO Finland
Rhinopharyngoscopy
4.5
12.7
46
114
EMB00
NOMESCO Finland
Excision of lesion of tonsil or adenoids
+∞
12.6
12
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
12.6
12
*
A04AD12
ATC
aprepitant; systemic
+∞
12.6
12
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
12.6
12
*
UJC01
NOMESCO Finland
Scopy of lower throat
31.2
11.7
15
5
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
9.7
11.7
23
25
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
11.5
11
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
11.5
11
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
11.5
11
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
11.5
11
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
11.5
11
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
11.0
167
1023
JN4AD
NOMESCO Finland
Body CT examination
7.1
10.9
26
39
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
61.8
10.7
12
*
L03AA02
ATC
filgrastim; parenteral
113.1
10.5
11
*
WZC30
NOMESCO Finland
Teaching
3.4
10.4
52
170
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
11.1
10.4
19
18
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.4
10.1
30
60
R4190
NOMESCO Finland
Nutritional therapy
8.0
10.1
22
29
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.2
9.7
29
59
WX110
NOMESCO Finland
Local anesthesy
2.1
9.5
251
1882
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
9.4
9
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
9.4
9
*
L02BA01
ATC
tamoxifen; oral
+∞
9.4
9
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
9.4
9
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
9.3
156
978
HAB40
NOMESCO Finland
Wedge excision of mammary gland
24.7
9.0
12
5
N02BE01
ATC
paracetamol; systemic, rectal
2.3
8.5
315
2649
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
92.1
8.4
9
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
92.1
8.4
9
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
92.1
8.4
9
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
8.4
158
1025
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
8.4
8
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
8.4
8
*
9680/3-C09.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of tonsil, NOS
+∞
8.4
8
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
8.4
8
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
17.7
8.1
12
7
JN6AD
NOMESCO Finland
CT of torso and neck
34.2
8.1
10
*
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.2
7.8
93
498
EHA10
NOMESCO Finland
Biopsy of palate
15.4
7.8
12
8
R21
ICPC
Throat symptom/complaint
2.3
7.6
80
404
A07AA02
ATC
nystatin; oral
3.6
7.5
33
99
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
81.7
7.4
8
*
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
81.7
7.4
8
*
J39.2
ICD-10 Finland
Other diseases of pharynx
11.2
7.4
13
12
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.8
7.3
46
176
21050
ICD-8 Finland
Benign neoplasm of buccal cavity and pharynx, Tonsil
+∞
7.3
7
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
7.3
7
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
7.3
7
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
7.3
7
*
L01BC06
ATC
capecitabine; oral
+∞
7.3
7
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
7.3
7
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
7.3
7
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
7.2
112
667
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.7
6.7
18
33
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.1
6.7
36
126
Z2221
NOMESCO Finland
Medical doctor
1.9
6.6
107
645
R4110
NOMESCO Finland
Physiotherapy
2.0
6.6
97
560
SXC03
NOMESCO Finland
Other oral or dental procedure
12.6
6.6
11
9
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.1
6.5
24
62
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.5
6.4
29
89
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
71.0
6.4
7
*
XW000
NOMESCO Finland
Bone marrow biopsy
5.7
6.4
17
31
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
6.3
70
361
9673/3-C09.9
ICD-O-3
Mantle cell lymphoma of tonsil, NOS
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
+∞
6.3
6
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
6.3
6
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
6.2
131
861
ZX120
NOMESCO Finland
Intravenous
3.1
6.2
33
115
SAA02
NOMESCO Finland
Basic examination of mouth
1.7
6.1
226
1762
K02.1
ICD-10 Finland
Caries of dentine
1.7
6.1
195
1459
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.8
6.0
24
67
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
98
95
13.20
92.28
1.7
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
257
1080
4.62
51.90
2.5
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
39
41
10.40
33.79
1.3
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
120
443
3.40
25.98
4.5
2.3
mmol/l
0.8
0.8
2.04
112
413
(3002256) Pathology report gross observation
80
257
3.62
21.19
1.3
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
130
563
2.91
20.85
1.6
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
25
9
29.43
18.94
1.2
1.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
185
999
2.54
18.76
4.5
2.0
mmol/l
2.4
2.4
1.37
162
833
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
246
1576
2.38
16.34
7.1
3.7
umol/l
10.2
11.3
1.60
239
1481
(3013650) Neutrophils [#/volume] in Blood by Automated count
265
1773
2.37
15.64
12.4
6.5
e9/l
4.0
4.2
1.06
232
1562
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
239
1547
2.28
15.02
5.5
5.2
mmol/l
1.2
1.2
0.37
197
1330
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
331
2474
2.67
14.86
9.5
5.3
u/l
76.2
74.8
0.34
321
2285
(3024561) Albumin [Mass/volume] in Serum or Plasma
206
1286
2.20
13.76
5.1
3.4
g/l
35.9
35.8
0.15
200
1188
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
213
1405
2.06
11.72
4.8
4.8
mmol/l
1.2
1.2
0.01
199
1257
(42870588) Differential panel, method unspecified - Blood
169
1040
2.05
11.09
6.4
5.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
106
546
2.26
10.99
3.9
2.0
mmol/l
2.5
2.4
1.58
94
467
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
48
169
3.08
10.74
3.5
1.5
ug/l
13.0
4.5
0.95
38
133
(3018418) pH of Serum or Plasma
148
895
2.02
9.98
4.4
2.8
ph
7.4
7.4
0.80
34
140
(3002030) Lymphocytes/100 leukocytes in Blood
220
1534
1.92
9.68
7.8
5.4
%
27.0
28.3
0.87
208
1434
(3021589) Normoblasts [#/volume] in Blood
209
1436
1.92
9.59
11.3
7.6
e9/l
0.0
0.0
0.50
174
1183
(3019069) Monocytes/100 leukocytes in Blood
216
1502
1.91
9.54
7.8
5.6
%
9.0
8.5
1.00
206
1407
(3018010) Neutrophils/100 leukocytes in Blood
217
1521
1.89
9.26
7.5
5.2
%
57.7
57.1
0.29
207
1428
(3019198) Lymphocytes [#/volume] in Blood
231
1653
1.90
9.23
7.8
5.2
e9/l
1.8
1.9
1.23
206
1464
(3001604) Monocytes [#/volume] in Blood
226
1612
1.88
9.06
7.5
5.2
e9/l
0.6
0.6
0.53
199
1407
(3006504) Eosinophils/100 leukocytes in Blood
213
1494
1.87
8.97
7.7
5.3
%
2.6
2.9
0.92
202
1396
(3006315) Basophils [#/volume] in Blood
226
1624
1.86
8.73
7.7
5.2
e9/l
0.0
0.0
0.54
198
1423
(3013115) Eosinophils [#/volume] in Blood
231
1676
1.85
8.61
7.7
5.5
e9/l
0.2
0.2
1.98
206
1489
(3022096) Basophils/100 leukocytes in Blood
206
1443
1.85
8.59
7.9
5.4
%
0.7
0.7
0.15
195
1347
(3030467) Casts [#/volume] in Urine by Automated count
132
830
1.87
7.57
3.4
2.7
e6/l
0.3
0.4
0.67
98
619
(40758558) Short blood count panel - Blood
119
726
1.90
7.48
8.4
4.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
107
635
1.92
7.29
1.5
1.3
g/l
2.2
2.6
1.42
61
384
(3021879) Hepatitis B virus core Ab [Presence] in Serum
47
203
2.48
7.13
1.3
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
119
738
1.86
7.06
1.3
1.3
u/ml
0.6
2.0
1.67
29
215
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
57
273
2.26
6.86
2.8
2.1
u/l
30.8
35.1
0.46
50
227
(36304419) Bacteria [Presence] in Urine
127
811
1.82
6.83
3.4
2.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
138
906
1.78
6.75
3.7
2.8
e6/l
31.6
142.2
0.85
105
696
(3018095) Leukocytes [#/volume] in Urine
159
1090
1.74
6.68
4.3
3.3
e6/l
134.7
122.2
0.06
113
763
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
10
15
6.81
6.34
2.1
1.3
ug/l
12.1
16.0
—
10
15
(3022145) Colonoscopy Study observation
65
339
2.09
6.32
1.2
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
307
2554
1.78
6.11
4.8
4.1
mm/h
12.5
11.1
1.00
286
2338
(3023368) Bacteria identified in Blood by Culture
119
768
1.77
6.08
4.8
3.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
368
3249
2.17
6.04
18.0
10.3
ml/min/173m2
80.9
80.6
0.08
324
2600
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
82
473
1.91
6.00
3.3
2.6
e6/l
1.9
2.7
0.55
45
250
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
86
512
1.86
5.69
2.8
2.5
e6/l
1.1
1.4
0.37
48
288
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
15
37
4.17
5.67
2.5
1.9
—
597.8
—
0
6
(3044640) Blood type and Crossmatch panel - Blood
132
901
1.68
5.43
2.8
2.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
155
1104
1.64
5.40
3.8
2.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
48
237
2.16
5.36
6.8
4.5
%
1.0
0.9
0.08
20
61
(3003458) Phosphate [Moles/volume] in Serum or Plasma
70
399
1.91
5.28
5.8
3.9
mmol/l
1.0
1.0
0.08
62
366
(3044889) 12 lead EKG panel
291
2434
1.65
5.15
4.4
3.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
67
380
1.91
5.13
2.0
2.2
%
23.3
24.1
0.16
58
329
(3026782) Osmolality of Urine
95
601
1.75
5.11
3.1
2.4
mosm/kgh2o
513.9
557.6
1.08
79
498
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
313
2670
1.70
5.11
5.1
3.8
pmol/l
14.6
14.8
0.38
293
2424
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
185
1395
1.59
5.01
4.5
3.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
361
3216
1.94
5.00
6.0
4.6
mu/l
2.0
2.3
0.40
337
2936
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
41
3.76
4.97
1.1
1.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
389
3567
2.45
4.91
19.5
13.7
mmol/l
139.6
139.8
0.79
380
3454
(40768443) Skin Pathology biopsy report
30
126
2.49
4.85
1.2
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
45
226
2.11
4.82
7.0
4.7
%
0.0
0.1
1.08
17
54
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
10
9.17
4.80
2.8
2.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
389
3576
2.40
4.72
19.8
13.7
mmol/l
4.0
4.0
1.08
380
3459
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
375
3400
2.07
4.69
19.1
11.4
mg/l
20.1
21.7
0.48
322
2613
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
40
194
2.18
4.68
1.8
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
5
14.20
4.59
1.1
2.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
59
335
1.89
4.49
3.1
2.1
umol/l
5.1
6.4
1.16
52
294
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
77
476
1.76
4.46
2.1
1.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
65
382
1.83
4.45
2.2
2.3
ug/g
88.1
131.2
1.16
44
293
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
53
292
1.93
4.42
3.8
2.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
96
633
1.67
4.40
2.7
2.2
e6/l
6.0
7.1
0.24
83
551
(3013826) Glucose [Moles/volume] in Serum or Plasma
238
1937
1.54
4.38
4.3
4.1
mmol/l
6.4
6.8
2.63
231
1799
(3007853) Bacteria identified in Skin by Aerobe culture
61
353
1.85
4.38
1.8
1.7
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
7
6
11.84
4.29
1.1
2.0
%
3.1
5.8
—
7
6
(21494814) CD8 cells/100 lymphocytes in Specimen
7
6
11.84
4.29
1.1
2.0
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
32
148
2.26
4.21
4.1
9.4
mmol/l
23.9
25.0
1.37
32
133
(3027315) Oxygen [Partial pressure] in Blood
17
57
3.07
4.17
1.7
2.4
kpa
8.4
8.5
0.09
17
57
(3013290) Carbon dioxide [Partial pressure] in Blood
17
57
3.07
4.17
1.7
2.4
kpa
5.1
5.0
0.21
17
57
(3026389) Candida sp identified in Specimen by Organism specific culture
14
42
3.41
4.08
1.5
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
125
896
1.57
4.04
3.2
2.3
umol/l
6858.8
7441.9
0.04
111
769
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
14
6.54
4.00
1.7
2.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
66
403
1.76
3.98
1.4
1.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
67
411
1.75
3.97
1.9
2.1
g/l
2.4
2.4
0.50
59
382
(3014765) Yersinia sp identified in Stool by Organism specific culture
25
108
2.40
3.84
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
34
169
2.10
3.77
1.2
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
165
1272
1.49
3.76
6.6
8.4
inr
1.1
1.3
1.57
58
351
(40761536) Microorganisms panel - Urine sediment
45
248
1.91
3.76
3.6
3.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
25
110
2.35
3.69
1.1
1.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
9
16
5.72
3.67
2.3
1.9
nmol/l
2.4
3.6
—
9
16
(3017143) Hepatitis C virus Ab [Presence] in Serum
54
321
1.78
3.56
1.5
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
269
2299
1.48
3.56
3.2
3.0
u/l
48.8
45.3
0.22
251
2156
(3045142) Bone marrow Pathology biopsy report
10
26
3.92
3.54
1.3
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
74
482
1.65
3.52
1.3
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
174
1370
1.47
3.51
2.4
2.2
nmol/l
76.3
77.9
0.28
149
1203
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
108
772
1.54
3.48
2.3
2.1
mg/l
3.4
3.1
0.30
91
656
(3025941) Bacteria identified in Stool by Culture
35
182
2.01
3.45
1.3
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
54
325
1.76
3.42
1.9
1.8
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
71
461
1.65
3.42
1.9
2.1
umol/l
13.7
13.8
0.03
63
423
(36660697) Celiac disease serology panel - Serum
45
257
1.84
3.38
1.2
1.2
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
7
10
7.10
3.37
1.1
2.3
e9/l
0.1
0.2
—
7
10
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
37
3.31
3.37
2.0
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
136
1027
1.48
3.36
2.5
2.2
u/l
54.2
57.3
0.63
125
956
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
176
1398
1.45
3.35
2.0
2.0
pmol/l
100.5
97.0
0.40
92
706
(3013512) EKG study
135
1021
1.48
3.30
3.9
3.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
98
693
1.54
3.30
2.5
2.0
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
30
152
2.05
3.19
1.1
1.1
—
88.5
—
0
6
(3002179) Metamyelocytes/100 leukocytes in Blood
39
217
1.88
3.18
6.6
4.6
%
0.5
0.4
0.14
11
45
(3009542) Hematocrit [Volume Fraction] of Blood
345
3136
1.59
3.16
18.4
12.3
%
39.9
40.4
0.55
239
2210
(3027945) Reticulocytes/100 erythrocytes in Blood
55
341
1.71
3.15
3.2
2.2
%
1.6
1.8
0.54
48
306
(3036481) Cortisol [Moles/volume] in Serum or Plasma
52
318
1.73
3.12
2.8
1.9
nmol/l
392.2
359.0
0.65
47
291
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
98
704
1.51
3.06
1.7
1.7
mg/l
0.8
1.0
0.63
73
554
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
13
45
2.95
3.05
2.1
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
102
741
1.50
3.01
6.8
4.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
14
51
2.81
3.01
1.6
2.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
14
51
2.81
3.01
1.2
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
14
51
2.81
3.01
1.2
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
265
2295
1.43
3.01
5.1
4.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
40
229
1.83
3.00
1.3
1.2
—
—
—
0
0
(3010421) pH of Blood
17
69
2.53
3.00
1.7
2.3
ph
7.4
7.4
0.59
17
57
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
15
57
2.69
2.99
1.1
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
23
108
2.20
2.96
1.1
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
13
46
2.89
2.94
1.5
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
38
216
1.84
2.92
7.8
4.8
%
0.0
1.9
0.54
13
49
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
52
326
1.68
2.86
1.7
1.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
24
117
2.12
2.83
1.3
1.8
g/l
1.4
1.4
0.18
17
100
(3000494) Fungus identified in Specimen by Culture
60
392
1.62
2.82
1.5
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
40
235
1.78
2.77
1.3
1.2
iu/ml
83.6
123.3
0.49
15
100
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
37
3.03
2.71
1.2
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
8
19
4.27
2.69
1.3
2.2
e9/l
1.1
1.0
—
8
12
(3002385) Erythrocyte distribution width [Ratio]
312
2809
1.45
2.68
23.5
13.6
%
14.0
13.6
2.61
301
2740
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
15
61
2.51
2.65
1.9
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
17
74
2.35
2.61
1.4
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
125
969
1.41
2.60
3.0
3.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
390
3698
1.91
2.58
13.3
8.6
u/l
26.8
25.8
0.52
382
3545
(3001122) Ferritin [Mass/volume] in Serum or Plasma
177
1459
1.37
2.54
2.9
2.6
ug/l
141.8
112.1
0.80
164
1341
(3003694) ABO and Rh group [Type] in Blood
104
785
1.43
2.50
1.5
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
193
1619
1.36
2.46
4.8
4.8
estimate
0.0
0.0
0.00
43
267
(46235355) HIV 1 and 2 tests - Meaningful Use set
71
500
1.51
2.42
1.7
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
15
64
2.39
2.41
1.9
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
192
1613
1.35
2.41
3.6
3.5
estimate
0.0
0.0
0.00
43
271
(3035637) Corticotropin [Mass/volume] in Plasma
10
35
2.90
2.32
1.5
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
14
59
2.42
2.31
1.6
2.1
%
14.5
16.3
—
6
29
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
367
3441
1.58
2.31
4.9
4.6
mmol/l
5.9
6.0
0.58
339
3132
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
27
149
1.87
2.30
1.1
1.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
194
1641
1.34
2.29
3.7
3.5
estimate
0.0
0.0
0.50
44
261
(3048929) Epstein Barr virus Ab [Presence] in Serum
17
79
2.20
2.28
1.1
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
30
172
1.80
2.28
1.9
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
37
226
1.70
2.27
4.9
7.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
18
86
2.14
2.26
1.3
1.3
ug/g
305.2
323.3
0.13
11
50
(1616796) Gas panel - Central venous blood
14
60
2.38
2.24
1.6
2.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
19
3.73
2.16
1.1
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
59
410
1.51
2.15
1.8
1.8
%
1.5
1.5
0.21
46
359
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
40
254
1.64
2.13
4.4
1.8
ml/min/173m2
66.7
66.0
0.06
23
105
(3019309) Folate [Moles/volume] in Red Blood Cells
84
628
1.42
2.11
1.9
1.7
nmol/l
1086.6
1182.2
0.44
64
464
(40760888) Immunoglobulin light chains.free panel - Serum
12
50
2.44
2.04
4.9
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
30
179
1.73
2.01
2.5
2.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
32
2.85
2.01
2.4
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
41
267
1.59
1.99
1.6
1.4
—
—
—
0
0
(3036489) Thrombin time
19
98
1.98
1.98
1.2
1.9
s
26.1
20.7
0.48
19
89
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
32
196
1.69
1.96
1.4
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
15
71
2.15
1.94
1.6
2.1
u/l
1418.5
2633.0
—
6
25
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
16
3.79
1.94
1.0
1.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
24
137
1.80
1.87
2.8
2.9
mmol/l
24.6
24.6
0.00
19
125
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
28
2.89
1.87
2.0
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
28
2.89
1.87
1.3
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
46
2.43
1.86
1.5
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
21
115
1.87
1.86
1.6
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
84
643
1.38
1.84
4.8
3.6
ng/l
310.2
320.8
0.02
68
491
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
12
4.20
1.83
1.2
1.5
%
110.8
94.2
—
5
12
(3007461) Platelets [#/volume] in Blood
398
3844
1.86
1.76
27.5
17.1
e9/l
253.2
249.6
0.49
389
3736
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
12
54
2.26
1.75
3.5
3.5
%
55.0
57.6
0.20
12
54
(3024731) MCV [Entitic volume]
398
3845
1.86
1.75
27.4
17.0
fl
91.2
91.0
0.43
393
3773
(3035941) MCH [Entitic mass]
398
3846
1.85
1.73
27.4
17.0
pg
30.3
30.3
0.13
393
3773
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
46
0.00
1.71
0.0
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
398
3847
1.84
1.71
27.5
17.1
e9/l
6.7
6.6
0.17
389
3729
(3026361) Erythrocytes [#/volume] in Blood
398
3847
1.84
1.71
27.4
17.1
e12/l
4.5
4.5
2.18
388
3728
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
48
0.00
1.71
0.0
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
378
3612
1.52
1.66
16.0
11.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
25
2.83
1.65
1.6
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
21
348
0.58
1.64
1.3
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
31
199
1.60
1.62
2.8
1.3
—
—
—
0
0
(44806118)
8
32
2.53
1.60
1.6
1.4
—
—
—
0
0
(44790048)
8
32
2.53
1.60
1.6
1.4
—
—
—
0
0
(44790049)
8
32
2.53
1.60
1.6
1.4
—
—
—
0
0
(44790047)
8
32
2.53
1.60
1.6
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
11
50
2.23
1.58
1.5
1.2
nmol/l
0.6
0.6
0.01
11
45
(3049717) Cytology report of Urine Cyto stain
17
93
1.86
1.54
2.6
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
104
846
1.31
1.53
4.0
3.7
estimate
0.0
0.0
0.00
43
262
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
5
15
3.36
1.52
3.6
2.4
—
1397.2
—
0
5
(3000492) Spirometry study
44
311
1.46
1.51
1.4
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
28
2.52
1.46
1.7
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
11
52
2.15
1.45
1.1
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
11
52
2.15
1.45
1.1
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
397
3850
1.72
1.45
27.7
17.1
g/l
134.1
136.8
3.34
392
3777
(3051651) Icteric interference index of Serum or Plasma
5
16
3.15
1.44
2.2
2.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
20
118
1.73
1.44
1.6
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
13
67
1.97
1.40
3.2
2.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
60
456
1.37
1.39
1.8
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
373
3576
1.43
1.38
5.0
5.1
mmol/l
2.8
2.8
0.48
337
3294
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
23
2.63
1.37
1.2
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
39
0.00
1.34
0.0
1.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
16
91
1.79
1.31
1.2
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
24
2.52
1.31
1.8
1.8
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
24
2.52
1.31
2.3
2.3
—
—
—
0
0
(4034850)
6
133
0.44
1.30
6.0
9.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
91
744
1.29
1.28
3.4
3.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
30
204
1.51
1.26
2.8
2.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
35
246
1.46
1.26
2.9
3.2
ng/l
75.3
75.6
0.01
30
219
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
12
63
1.93
1.24
1.7
1.7
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
19
116
1.67
1.23
1.5
1.2
—
0.9
—
0
5
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
366
3511
1.36
1.22
4.5
4.6
mmol/l
4.7
4.7
0.07
328
3244
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
26
2.33
1.19
1.3
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
39
2.07
1.16
2.0
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
20
2.52
1.15
2.6
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
30
2.36
1.13
2.1
2.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
44
331
1.37
1.11
4.0
7.4
mmol/l
0.0
1.7
2.03
38
265
(3052851) Hemolysis interference index of Serum or Plasma
14
81
1.75
1.10
2.3
3.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
96
807
1.25
1.08
1.5
1.5
nmol/l
18.4
21.4
1.53
80
674
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
88
733
1.25
1.07
1.8
1.7
pmol/l
456.9
438.9
0.20
72
595
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
82
1.73
1.06
1.2
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
31
221
1.44
1.06
1.6
2.3
nmol/l
12.9
14.8
0.55
24
200
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
33
2.14
1.06
1.7
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
46
1.98
1.04
1.2
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
22
2.29
1.03
1.0
1.6
%
9.0
10.5
—
5
22
(3025130) Human papilloma virus identified in Specimen
7
34
2.08
1.03
2.0
1.5
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
25
172
1.48
1.02
5.1
9.6
%
0.6
0.7
0.93
25
172
(3030905) Polymorphonuclear cells [#/volume] in Blood
10
53
1.91
1.02
3.2
3.0
e9/l
3.9
4.5
—
10
53
(3045414) Leukocytes [Presence] in Urine
20
131
1.55
1.02
2.8
1.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
61
489
1.29
1.01
1.6
1.3
titre
404.4
533.0
0.40
18
123
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
64
517
1.28
1.00
1.5
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
23
2.19
0.98
1.6
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
54
1.87
0.97
2.4
1.6
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
31
0.00
0.96
0.0
1.3
—
71.9
—
0
9
(3015171) Extractable nuclear Ab [Units/volume] in Serum
21
142
1.50
0.94
1.4
1.2
—
0.3
—
0
11
(3022217) INR in Platelet poor plasma by Coagulation assay
55
440
1.29
0.94
14.1
23.3
inr
1.1
1.3
—
7
68
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
150
1337
1.19
0.94
3.7
3.5
ng/l
29.9
62.5
0.64
94
918
(3004616) Nuclear Ab [Presence] in Serum
9
52
1.75
0.93
1.2
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
28
2.16
0.92
3.0
2.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
142
1262
1.19
0.91
3.6
3.5
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
25
177
1.44
0.90
5.1
9.4
%
1.4
1.5
0.16
25
177
(3023520) Reticulocytes [#/volume] in Blood
33
246
1.37
0.90
3.2
2.6
e9/l
59.1
70.6
0.80
23
194
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
29
2.08
0.89
3.2
3.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
111
1.55
0.89
2.5
1.2
g/l
7.0
7.5
—
10
87
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
111
1.55
0.89
2.5
1.2
g/l
5.1
3.9
—
10
82
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
111
1.55
0.89
2.5
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
43
1.88
0.87
1.3
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
44
1.83
0.86
2.1
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
44
1.83
0.86
1.6
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
16
104
1.56
0.86
1.8
2.6
g/l
0.1
0.2
—
5
32
(4268621)
6
32
1.89
0.82
3.0
2.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
33
1.83
0.79
4.0
2.5
pg
35.2
33.6
—
6
33
(3019225) pH of Specimen
42
333
1.29
0.78
2.7
3.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
38
298
1.30
0.77
2.9
2.7
mmol/l
2.1
2.1
0.05
29
240
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
99
1.53
0.76
1.5
3.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
348
3361
1.22
0.76
4.1
4.1
mmol/l
1.3
1.3
0.07
309
3070
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
53
1.71
0.76
2.0
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
39
1.81
0.73
2.0
2.8
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
38
302
1.28
0.71
2.8
2.7
kpa
5.9
5.8
0.19
33
293
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
41
1.72
0.70
2.3
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
119
0.58
0.68
1.0
1.6
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
5
92
0.54
0.67
1.2
1.2
e6/l
20.2
1357.5
—
5
72
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
5
92
0.54
0.67
1.0
1.1
e6/l
1.2
38.5
—
5
70
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
43
1.64
0.67
1.7
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
32
251
1.30
0.66
1.5
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
78
1.55
0.66
1.3
1.4
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
5
29
1.73
0.64
1.0
1.0
—
0.0
—
0
5
(3023430) Cat dander IgE Ab [Units/volume] in Serum
5
29
1.73
0.64
1.0
1.1
—
1.3
—
0
9
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
49
1.64
0.62
1.0
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
32
254
1.28
0.62
2.2
2.3
kpa
4.2
4.6
1.00
27
245
(3041096) Erythrocytes [Presence] in Urine by Automated
100
893
1.16
0.60
3.4
3.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
358
3486
1.20
0.59
4.5
4.6
mmol/l
1.5
1.5
0.84
316
3205
(3015736) pH of Urine
140
1283
1.14
0.59
3.2
3.3
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
12
81
1.50
0.57
1.1
2.0
%
78.1
91.0
0.96
12
76
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
54
1.49
0.57
1.8
2.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
54
1.49
0.57
1.6
2.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
103
1141
0.87
0.57
4.5
4.0
mg/mmol
5.4
7.3
0.36
65
689
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
108
974
1.15
0.57
1.5
1.7
mmol/l
1.3
1.4
0.17
86
818
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
6
36
1.68
0.57
1.3
1.1
—
94.4
—
0
5
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
17
124
1.39
0.56
1.4
1.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
75
659
1.17
0.56
1.4
1.3
iu/ml
20.4
37.3
1.81
15
214
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
107
1.42
0.56
2.7
1.2
g/l
3.1
3.0
—
10
84
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
25
313
0.79
0.52
1.7
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
13
179
0.72
0.51
1.5
1.8
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
10
67
1.50
0.50
1.6
2.2
kpa
8.2
7.9
—
10
60
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
16
119
1.36
0.49
2.7
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
46
1.53
0.48
1.4
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
47
1.50
0.48
1.3
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
47
1.50
0.48
1.4
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
48
1.47
0.47
1.3
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
17
129
1.33
0.46
2.8
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
13
94
1.40
0.46
1.6
1.4
miu/ml
94.9
261.0
—
7
45
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
51
1.38
0.44
1.0
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
57
1.41
0.42
1.5
1.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
33
1.52
0.41
3.4
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(4198724)
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
79
1.40
0.41
1.2
1.6
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
17
0.00
0.40
0.0
1.1
—
40.4
—
0
10
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
1620.9
—
0
17
(3014133) Dog dander IgE Ab [Units/volume] in Serum
5
34
1.48
0.40
1.0
1.1
—
1.4
—
0
10
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
8
61
1.32
0.39
1.3
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
5
36
1.39
0.38
2.6
1.8
u/ml
3.5
105.4
—
5
36
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
8
112
0.71
0.37
1.4
1.8
nmol/l
37.0
40.5
—
8
107
(3003327) Ova and parasites identified in Stool by Light microscopy
15
116
1.30
0.37
2.3
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
9
71
1.27
0.36
1.3
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
9
71
1.27
0.36
1.4
2.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
45
1.34
0.34
1.3
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
45
1.34
0.34
1.3
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
21
173
1.23
0.33
3.6
3.5
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
16
128
1.26
0.32
1.6
1.8
—
142.5
—
0
8
(3017732) Neutrophils [#/volume] in Blood
27
230
1.19
0.32
1.4
2.5
e9/l
4.7
3.8
0.96
22
172
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
53
1.33
0.31
1.3
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
53
1.33
0.31
1.3
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
53
1.33
0.31
1.3
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
53
1.33
0.31
1.3
1.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
112
1052
1.09
0.30
2.5
2.1
u/l
188.6
232.1
0.23
102
989
(3028707) Methadone [Presence] in Urine by Screen method
7
56
1.25
0.29
1.1
1.3
—
—
—
0
0
(1002224) Polysomnography panel
19
159
1.20
0.27
1.1
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
66
1.22
0.27
1.0
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
72
0.69
0.26
2.0
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
87
1.27
0.24
1.1
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
67
623
1.09
0.23
1.4
1.3
u/ml
3.6
11.7
1.55
24
237
(4062490)
5
38
1.32
0.23
1.0
1.3
—
—
—
0
0
(3020891) Body temperature
10
125
0.80
0.23
4.2
4.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
19
220
0.86
0.22
1.4
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
16
135
1.19
0.21
1.7
2.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
42
1.19
0.21
1.2
1.1
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.1
—
0.7
—
0
6
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(44806420)
0
11
0.00
0.21
0.0
2.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
334
3291
1.08
0.21
5.8
6.0
mmol/mol
39.3
40.0
0.87
307
3059
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
102
0.78
0.21
1.6
1.4
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
12
0.00
0.21
0.0
5.8
—
25.3
—
0
12
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
43
1.16
0.21
1.0
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
80
1.26
0.20
1.2
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
48
1.25
0.20
2.5
1.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
48
1.25
0.20
1.3
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
48
1.25
0.20
2.3
1.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
18
155
1.17
0.20
1.8
2.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
12
140
0.85
0.15
1.0
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
297
2929
1.05
0.15
23.4
15.0
g/l
331.2
332.6
1.75
292
2910
(3012516) Albumin [Mass/volume] in Urine
104
1079
0.95
0.14
3.1
3.2
mg/l
48.6
178.8
0.78
67
661
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
16
141
1.14
0.14
5.1
10.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
216
2120
1.04
0.13
3.4
2.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
15
168
0.89
0.12
4.6
3.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
79
760
1.05
0.12
3.5
3.6
kg/l
1.0
1.0
—
10
103
(1761482) Bacteria [#/volume] in Urine by Culture
11
95
1.16
0.11
3.3
4.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
111
1143
0.96
0.11
3.3
3.1
mmol/l
7.9
7.6
0.32
92
950
(3016879) Cocaine [Presence] in Urine
12
105
1.15
0.11
1.1
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
23
212
1.09
0.10
4.0
3.3
mmol/l
3.6
2.0
1.19
15
158
(3023511) Choriogonadotropin [Units/volume] in Urine
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
102
992
1.04
0.09
2.7
2.9
ng/l
1877.3
1116.0
0.79
84
836
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
48
1.04
0.09
1.0
1.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
63
0.79
0.08
1.0
1.2
u/l
20.0
14.6
—
5
55
(3021788) Differential panel - Synovial fluid
7
66
1.06
0.08
2.1
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
41
392
1.05
0.07
1.6
1.7
—
—
—
0
0
(4010399)
28
266
1.06
0.06
1.6
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
81
827
0.97
0.05
3.6
3.6
%
22.7
24.0
0.44
44
361
(3000764) Benzodiazepines [Presence] in Urine
12
110
1.09
0.05
1.1
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
12
110
1.09
0.05
1.1
1.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
16
171
0.93
0.05
2.8
2.5
mmol/l
25.6
25.3
0.12
16
166
(1761868) Lipid panel - Serum or Plasma
129
1308
0.98
0.05
2.8
2.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
12
111
1.08
0.04
1.1
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
12
111
1.08
0.04
1.1
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
28
271
1.04
0.02
3.5
2.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
102
1030
0.99
0.02
4.1
3.7
ug/l
1.7
1.9
0.31
89
924
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
47
462
1.02
0.01
4.1
4.8
%
29.7
32.4
0.97
30
297
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
11
112
0.98
0.00
2.9
1.6
g/l
1.2
1.2
0.02
11
107
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
32
319
1.00
0.00
2.4
2.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
57
571
1.00
0.00
2.5
2.6
ug/l
0.7
0.7
0.43
34
366
(3019060) Gas panel - Arterial blood
19
193
0.98
0.00
2.7
5.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
24
237
1.01
0.00
1.3
1.4
—
41.8
—
0
15
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
95
1.05
0.00
1.6
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
115
0.96
0.00
1.7
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
29
285
1.02
0.00
2.1
1.9
—
—
—
0
0
(4094501)
10
104
0.96
0.00
1.2
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
46
456
1.01
0.00
7.0
6.7
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
13.8
—
0
6
(4133840)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
51
0.98
0.00
1.0
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
82
0.98
0.00
1.0
1.3
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
11
110
1.00
0.00
4.0
2.1
ug/l
708.8
669.2
0.03
11
102
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
1.8
—
0
7
(3024932) HLA-DR beta [Type]
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
9
0.00
0.00
0.0
7.9
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
60
1.00
0.00
1.0
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
6
65
0.92
0.00
1.0
1.6
nmol/l
0.9
0.9
—
6
52
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
7.2
—
0
8
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
82
0.98
0.00
1.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_TONSIL_EXALLC – Benign neoplasm: Tonsil
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).